Wonder of wonders, miracle of miracles: the unprecedented speed of COVID-19 science.
作者信息
Saag Michael
机构信息
University of Alabama at Birmingham, Birmingham, Alabama.
出版信息
Physiol Rev. 2022 Jul 1;102(3):1569-1577. doi: 10.1152/physrev.00010.2022. Epub 2022 Apr 21.
Abstract
摘要
相似文献
1
Wonder of wonders, miracle of miracles: the unprecedented speed of COVID-19 science.神奇啊，真是神奇：新冠病毒研究速度空前。
Physiol Rev. 2022 Jul 1;102(3):1569-1577. doi: 10.1152/physrev.00010.2022. Epub 2022 Apr 21.
2
What is a miracle?什么是奇迹？
South Med J. 2007 Dec;100(12):1223-8. doi: 10.1097/SMJ.0b013e31815a9784.
3
Seven Wonders of Medical Science-Modern Miracles.医学科学的七大奇迹——现代奇迹
Cal West Med. 1934 Nov;41(5):325-8.
4
Seven Wonders of Medical Science-Modern Miracles.医学科学七大奇迹——现代奇迹
Cal West Med. 1938 Oct;49(4):260-3.
5
[The miracle and science].[奇迹与科学]
Accao Med. 1946 Jul-Sep;10(37):34-55.
6
Waiting for a miracle... miracles, miraclism, and discrimination.等待奇迹……奇迹、奇迹主义与歧视。
South Med J. 2007 Dec;100(12):1259-62. doi: 10.1097/SMJ.0b013e31815a9a09.
7
Mystery and Miracle in Nursing: A Preliminary Unitary Appreciative Inquiry.护理的奥秘与奇迹：初步整体欣赏性探究。
ANS Adv Nurs Sci. 2024;47(2):218-230. doi: 10.1097/ANS.0000000000000531. Epub 2024 May 2.
8
[Miracles and wonders].[奇迹与奇观]
Med Gen Fr. 1950 Dec 10;10(23):341-2.
9
Miracles and the limits of medical knowledge.奇迹与医学知识的局限。
Med Health Care Philos. 2002;5(1):1-9. doi: 10.1023/a:1014275232713.
10
Tracing the Boundaries of the Natural: Medicine and the Inquiry on Miracles in Early Modern Canonization Trials.探寻自然的边界：近代早期封圣审判中的医学与奇迹探究
J Hist Med Allied Sci. 2019 Oct 1;74(4):369-390. doi: 10.1093/jhmas/jrz053.
引用本文的文献
1
Artificial intelligence in vaccine research and development: an umbrella review.疫苗研发中的人工智能：一项综合综述
Front Immunol. 2025 May 8;16:1567116. doi: 10.3389/fimmu.2025.1567116. eCollection 2025.
2
Real-world COVID-19 vaccine effectiveness in Zimbabwe: A test-negative case-control study.津巴布韦新冠疫苗在现实世界中的有效性：一项检测呈阴性的病例对照研究。
J Public Health Afr. 2025 Feb 19;16(1):695. doi: 10.4102/jphia.v16i1.695. eCollection 2025.
3
Sociodemographic Factors Associated With Established and Novel Antenatal Vaccination Uptake in a Cohort of Pregnant Women in Uganda.乌干达一组孕妇中与已确立和新型产前疫苗接种率相关的社会人口学因素
Pediatr Infect Dis J. 2025 Feb 1;44(2S):S92-S96. doi: 10.1097/INF.0000000000004644. Epub 2025 Feb 14.
4
Sustainable integration of artificial intelligence and machine learning approaches within the African infectious disease vaccine research and development ecosystem.人工智能和机器学习方法在非洲传染病疫苗研发生态系统中的可持续整合。
Front Pharmacol. 2024 Dec 17;15:1499079. doi: 10.3389/fphar.2024.1499079. eCollection 2024.
5
"Why would we?" A qualitative study on COVID-19 vaccination decision making among Ukrainian economic female migrants in Poland.为什么要这样做？波兰的乌克兰经济女性移民对 COVID-19 疫苗接种决策的定性研究。
Front Public Health. 2024 Aug 13;12:1380627. doi: 10.3389/fpubh.2024.1380627. eCollection 2024.
6
The Seraph 100 Microbind Affinity Blood Filter Does Not Alter Levels of Circulating or Mucosal Antibodies in Critical COVID-19 Patients.Seraph 100微结合亲和血液过滤器不会改变重症COVID-19患者循环抗体或黏膜抗体的水平。
Antibodies (Basel). 2024 Aug 6;13(3):65. doi: 10.3390/antib13030065.
7
Synthesis of optically active SARS-CoV-2 Mpro inhibitor drug nirmatrelvir (Paxlovid): an approved treatment of COVID-19.光学活性 SARS-CoV-2 Mpro 抑制剂药物奈玛特韦（Paxlovid）的合成：一种已批准用于治疗 COVID-19 的药物。
Org Biomol Chem. 2023 Jul 19;21(28):5768-5774. doi: 10.1039/d3ob00653k.
8
The SARS-CoV-2 spike S1 protein induces global proteomic changes in ATII-like rat L2 cells that are attenuated by hyaluronan.SARS-CoV-2 刺突蛋白 S1 诱导类似于 ATII 的大鼠 L2 细胞中的全蛋白质组变化，透明质酸可减弱这种变化。
Am J Physiol Lung Cell Mol Physiol. 2023 Apr 1;324(4):L413-L432. doi: 10.1152/ajplung.00282.2022. Epub 2023 Jan 31.
本文引用的文献
1
Multiple early factors anticipate post-acute COVID-19 sequelae.多种早期因素预示着急性新冠病毒感染后会出现长期新冠症状。
Cell. 2022 Mar 3;185(5):881-895.e20. doi: 10.1016/j.cell.2022.01.014. Epub 2022 Jan 25.
2
Lipid Nanoparticle Delivery Systems to Enable mRNA-Based Therapeutics.用于实现基于mRNA的治疗药物的脂质纳米颗粒递送系统。
Pharmaceutics. 2022 Feb 11;14(2):398. doi: 10.3390/pharmaceutics14020398.
3
Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with Covid-19.奈玛特韦片/利托那韦片组合包装口服药用于伴有进展为重症高风险因素的 COVID-19 门诊患者。
N Engl J Med. 2022 Apr 14;386(15):1397-1408. doi: 10.1056/NEJMoa2118542. Epub 2022 Feb 16.
4
HIV and SARS-CoV-2: Tracing a Path of Vaccine Research and Development.HIV 和 SARS-CoV-2：疫苗研发的溯源之路。
Curr HIV/AIDS Rep. 2022 Feb;19(1):86-93. doi: 10.1007/s11904-021-00597-4. Epub 2022 Jan 28.
5
Freedom, Rights, and Vaccine Refusal: The History of an Idea.自由、权利与疫苗抵制：一个理念的历史。
Am J Public Health. 2022 Feb;112(2):234-241. doi: 10.2105/AJPH.2021.306504.
6
Tixagevimab and Cilgavimab (Evusheld) for Pre-Exposure Prophylaxis of COVID-19.替沙格韦单抗和西加韦单抗（恩适得）用于新型冠状病毒肺炎暴露前预防
JAMA. 2022 Jan 25;327(4):384-385. doi: 10.1001/jama.2021.24931.
7
Communicating science and protecting scientists in a time of political instability.在政治不稳定时期传播科学和保护科学家
Trends Mol Med. 2022 Mar;28(3):173-175. doi: 10.1016/j.molmed.2022.01.001. Epub 2022 Jan 18.
8
Striking antibody evasion manifested by the Omicron variant of SARS-CoV-2.奥密克戎变异株对 SARS-CoV-2 表现出明显的抗体逃逸。
Nature. 2022 Feb;602(7898):676-681. doi: 10.1038/s41586-021-04388-0. Epub 2021 Dec 23.
9
COVID-19 hospitalizations and deaths averted under an accelerated vaccination program in northeastern and southern regions of the USA.美国东北部和南部地区加速疫苗接种计划避免的新冠住院和死亡情况。
Lancet Reg Health Am. 2022 Feb;6:100147. doi: 10.1016/j.lana.2021.100147. Epub 2021 Dec 29.
10
Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized Patients.莫努匹韦片用于非住院 COVID-19 患者的口服治疗。
N Engl J Med. 2022 Feb 10;386(6):509-520. doi: 10.1056/NEJMoa2116044. Epub 2021 Dec 16.
Zotero 插件